1Department of Surgery, Yeungnam University Hospital, Daegu, Korea
2Department of Surgery, Yeungnam University College of Medicine, Daegu, Korea
Copyright © 2021 Yeungnam University College of Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of interest
No potential conflicts of interest relevant to this article were reported.
Author contributions
Conceptualization: CYJ, JMB; Investigation and Resources: CYJ; Writing-original draft: CYJ, JMB; Writing-review & editing: JMB.
Previous presentations
The summary of this review was presented in the Acute and Critical Care Conference 2020 and the 40th Annual Meeting of Korean Society of Critical Care Medicine.
Based on Reintam Blaser et al. [21].
IAH, intraabdominal hypertension; IAP, intraabdominal pressure; BW, body weight; kJ, kilojoules; APP, abdominal perfusion pressure.
Material | Effect |
---|---|
Epidermal growth factor [60] | Improve gut apoptosis, proliferation, and permeability |
Glucagon-like peptide-2 [61] | Promote sufficient gut hypertrophy |
Membrane permeant inhibitor of myosin light chain kinase [62] | Improve intestinal permeability |
Mucus surrogate [63] | Prevent trauma/hemorrhagic shock-induced gut injury |
Pharmacologic vagus nerve agonist [64] | Attenuate toxic mesenteric lymph-induced lung injury |